Liver Cancer News

2025

February 2025

VIDEO: Unresectable HCC with Post-TACE Progression

VIDEO: Initial Treatment Options for Liver-Confined Unresectable HCC

FDA Grants Fast Track Designation to RZ-001 for HCC

NHS Warns Symptom In Your Right Shoulder Could Be Sign Of Liver Cancer

Understanding Liver Cancer: Signs, Prevention, And Latest Treatments

Video: Signs of Dying Liver: When To Get A Liver Transplant?

ADDING MULTIMEDIA ReCerise Signs New Research Collaboration Agreement towards Development of Innovative Treatment for Hepatocellular Carcinoma

New Liver Cancer Models Could Enable Precision Medicine

Key HCC Trial Data Establish the Role of Later-Line Cabozantinib and Raise Further Frontline Questions

New Experimental Models Are Created That Recapitulate Human Hepatocellular Carcinoma To Advance Personalised Medicine

Novel Therapeutic Approaches Targeting The Wnt Pathway In Hepatocellular Carcinoma

Pancreatic and Liver Cancer Advances Offer Hope in the Southwest

Rznomics Inc. Liver Cancer Drug Candidate Secures Fast-Track Designation

DAA, Interferon HCV Treatments Result in Similar Hepatocellular Carcinoma Risk

Video: How I Treat Advanced Hepatocellular Carcinoma: Mastering Immunotherapy for Optimal Outcomes

Guardian Molecule Keeps Cells On Track: New Perspectives For The Treatment Of Liver Cancer

Older Age Predicts Worse Survival in Patients With HCC, Comorbidity Role Unclear

FDA Grants Fast Track Designation to Amezalpat for Hepatocellular Carcinoma

MRI Model Predicts Pathologic Features Of Liver Cancer

New Study Offers Hope To Patients With Advanced Liver Cancer, Cirrhosis

Chronic Liver Patients Helped Attend Appointments

2025 ACS Report: Four Cancers Have Rising Death Rates

Dose-Dependent Link Seen for Alcohol, Cirrhosis, Liver Cancer in Patients With Hep B

Genetic Analysis Reveals PAH as a Risk Factor for Liver Cancer

Nivolumab Combo Earns Positive CHMP Opinion in Advanced Liver Cancer

January 2025

Researchers Identify A New Therapeutic Target To Overcome Immunotherapy Resistance In Patients With Solid Tumors

Love Your Liver: Blue Faery Amplifies Health Awareness During Black History Month

TACE Plus Camrelizumab and Apatinib Improves PFS in Liver Cancer Trial

Adjuvant Cell Therapy Reduces Recurrence Risk in Early-Stage Liver Cancer

Study: Bile Acid Supplement Shows Promise for Liver Cancer

Genetic Analysis Reveals PAH as a Risk Factor for Liver Cancer

Video: IMbrave050 Trial Design: Adjuvant Therapy for Early-Stage Hepatocellular Carcinoma

Promising Results for Triplet Blockade Therapy in Unresectable Hepatocellular Carcinoma

An International Project Involving IBB-CSIC-IDIBAPS Aims To Study The Relationship Between Hypercaloric Diets And Liver Cance

An Energy Trap For Tumor Cells: Researchers Find Enzyme Blockade Halts Liver Cancer Growth

NiKang Therapeutics® Announces First Patient Dosed in a Phase 1b/2 Study of NKT2152 in Combination with Standard-of-Care in First-Line Regimen for Hepatocellular Carcinoma

TACE Plus Lenvatinib/Pembrolizumab Boosts PFS in Unresectable Liver Cancer

Death Rates From Liver Cancer Double In The Last 20 Years

New Research Sheds Light On Changing Liver Cancer Trends

Breakthrough Treatment for Liver Cancer Shows Big Promise in Global Study

FDA Grants Orphan Drug Designation to Amezalpat in Hepatocellular Carcinoma

Abbreviated MRI for Hepatocellular Carcinoma: What a New Meta-Analysis Reveals

Study Reveals How Fatty Liver Disease Leads To Liver Cancer

For past liver cancer news, please visit our Liver Cancer News Archives.